The INFLUENZA VIRUS VACCINE is a the manufacturer industrial component. Key specifications include valence: TRIVALENT, immediate_container_type: SYRINGE-NEEDLE UNIT, protective_storage_feature: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING, immediate_container_quantity: 10, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, part_name_assigned_by_controlling_agency: INFLUENZA VIRUS VACCINE USP SPLIT TRIVALENT 0.25ML DOSE SYRINGE-UNIT 10S. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-530-1765, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| valence | TRIVALENT |
| immediate_container_type | SYRINGE-NEEDLE UNIT |
| protective_storage_feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| immediate_container_quantity | 10 |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| part_name_assigned_by_controlling_agency | INFLUENZA VIRUS VACCINE USP SPLIT TRIVALENT 0.25ML DOSE SYRINGE-UNIT 10S |
| american_hospital_formulary_service_classification_number | 801202 |
| NSN | 6505-01-530-1765 |
| IMMEDIATE CONTAINER QUANTITY | 10 |
| IMMEDIATE CONTAINER TYPE | SYRINGE-NEEDLE UNIT |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 801202 |
| VALENCE | TRIVALENT |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | INFLUENZA VIRUS VACCINE USP SPLIT TRIVALENT 0.25ML DOSE SYRINGE-UNIT 10S |
| SPECIAL FEATURES | SPLIT SURFACE ANTIGEN ONLY; PRESERVATIVE-FREE; 0.25ML SYRINGE (PEDIATRIC), 10'S; SUBCUTANEOUS OR INTRAMUSCULAR ADMINISTRATION; FOR IMMUNIZING PERSONS 6-35 MONTHS OF AGE; FOR 2005-2006 FLU SEASON; VIRUS STRAINA/NEW CALEDONIA/20/1999 (H1N1)-LIKEA/CALIFORNIA/07/2004 (H3N2)-LIKEB/SHANGHI/361/2002-LIKE; DO NOT USE IF IT HAS BEEN FROZEN |